+629.1%
MRNA vs CHD
+56.6%
+572.5%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CHD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.4% | -2.0% | -3.1% |
| 7D | -10.1% | -4.2% | -5.9% | -9.3% |
| 30D | +126.7% | -7.6% | +134.3% | +130.3% |
| 3M | +184.1% | -1.6% | +185.7% | +184.7% |
| 6M | +143.3% | -6.3% | +149.6% | +145.9% |
| YTD | +359.9% | +14.6% | +345.3% | +344.1% |
| 1Y | +454.2% | +1.6% | +452.6% | +449.3% |
| 3Y | +26.0% | +3.1% | +22.8% | +22.1% |
| 5Y | -70.3% | +21.1% | -91.3% | -73.4% |
| All | +629.1% | +56.6% | +572.5% | +469.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CHD.
Daily Out/Under-Performance
Portfolio return minus CHD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CHD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling